Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daxiang Biotech develops and manufactures advanced human organoids-on-chips and related microphysiological systems. Their IBAC® platform combines organoid and organ chip technologies to create highly biomimetic, high-throughput in vitro models. These are used by pharmaceutical companies, CROs, and academic researchers for drug discovery, toxicology testing, disease modeling, and personalized medicine. The company has raised significant venture funding to expand R&D capabilities and business reach.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Daxiang Biotech.